Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum Proteasome

[Image: see text] The Plasmodium proteasome represents a potential antimalarial drug target for compounds with activity against multiple life cycle stages. We screened a library of human proteasome inhibitors (peptidyl boronic acids) and compared activities against purified P. falciparum and human 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Stanley C., Gillett, David L., Spillman, Natalie J., Tsu, Christopher, Luth, Madeline R., Ottilie, Sabine, Duffy, Sandra, Gould, Alexandra E., Hales, Paul, Seager, Benjamin A., Charron, Carlie L., Bruzzese, Frank, Yang, Xiaofeng, Zhao, Xiansi, Huang, Shih-Chung, Hutton, Craig A., Burrows, Jeremy N., Winzeler, Elizabeth A., Avery, Vicky M., Dick, Lawrence R., Tilley, Leann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257627/
https://www.ncbi.nlm.nih.gov/pubmed/30373366
http://dx.doi.org/10.1021/acs.jmedchem.8b01161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257627/
https://www.ncbi.nlm.nih.gov/pubmed/30373366
http://dx.doi.org/10.1021/acs.jmedchem.8b01161

Ejemplares similares